Literature DB >> 15749161

Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarization.

Eva Delpón1, Ricardo Caballero, Ricardo Gómez, Lucía Núñez, Juan Tamargo.   

Abstract

Angiotensin II and aldosterone produce pro-arrhythmic effects by several mechanisms, including the modulation of voltage-dependent K(+) channels involved in human cardiac repolarization. Drugs that inhibit the renin-angiotensin-aldosterone system exert anti-arrhythmic actions that are related to the blockade of the pro-arrhythmic actions of angiotensin II and aldosterone. These anti-arrhythmic actions include inhibition of electrical and structural cardiac remodeling, inhibition of neurohumoral activation, reduction of blood pressure and stabilization of electrolyte disturbances. In this article, several angiotensin II AT(1) receptor antagonists (candesartan, E3174, eprosartan, irbesartan and losartan) and aldosterone receptor antagonists (canrenoic acid and spironolactone) that directly modulate the activity of the voltage-dependent K(+) channels are reviewed; the effects of these antagonists might be useful in the prevention and treatment of cardiac arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749161     DOI: 10.1016/j.tips.2005.01.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  6 in total

Review 1.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

2.  Angiotensin II induces afterdepolarizations via reactive oxygen species and calmodulin kinase II signaling.

Authors:  Zhenghang Zhao; Nadezhda Fefelova; Mayilvahanan Shanmugam; Peter Bishara; Gopal J Babu; Lai-Hua Xie
Journal:  J Mol Cell Cardiol       Date:  2010-11-06       Impact factor: 5.000

Review 3.  Cardiac fibroblast: the renaissance cell.

Authors:  Colby A Souders; Stephanie L K Bowers; Troy A Baudino
Journal:  Circ Res       Date:  2009-12-04       Impact factor: 17.367

4.  Inhibition of the rapid component of the delayed rectifier potassium current in ventricular myocytes by angiotensin II via the AT1 receptor.

Authors:  Y H Wang; C X Shi; F Dong; J W Sheng; Y F Xu
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

5.  The role of the renin-angiotensin system blocking in the management of atrial fibrillation.

Authors:  Brett Cliff; Naveed Younis; Salam Hama; Handrean Soran
Journal:  J Drug Assess       Date:  2012-03-05

6.  Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2.

Authors:  Lena Rivard; Michelle Samuel; Annik Fortier; Marie-Claude Guertin; Paul Khairy; Denis Roy; Mario Talajic; Jean-Claude Tardif
Journal:  CJC Open       Date:  2021-05-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.